 |
Pharmacy units offered to S3G BSc, S3V BBiotech
and M3M BMedRes |
 |
|
Please see the School of Pharmacy before
enrolling in any of these units (places in some units may be subject
to quota due to lab space). Refer to the UTas
Handbook for further clarification regarding these units.
| Year |
Unit Code |
Unit Title |
Weight |
Semester
|
| Year 2 units |
CSA232 |
Pharmacology [BSc, BBiotech,
BMedRes] |
12.5 % |
1
|
| |
CSA233 |
Pharmacology [BSc, BBiotech,
BMedRes] |
12.5 % |
2 |
| |
CSA227 |
Medicinal
Chemistry (Pharmacy) [BSc, BMedRes] |
12.5 % |
2 |
| Year 3 units |
CSA313 |
Clinical Pharmacokinetics
3 [BSc, BBiotech, BMedRes] |
12.5 % |
2 |
| |
CSA342 |
Chemotherapy and Infection [BBiotech, BMedRes] |
6.25 % |
1 |
| |
CSA343 |
Chemotherapy and Infection
[BBiotech, BMedRes]] |
6.25 % |
2 |
| |
CSA333 |
Toxicology [BSc, BBiotech] |
12.5 % |
1 |
Pharmacology
CSA232 |
Provides an introduction
to the study of drugs: chemicals which affect living systems.
General principles of drug action and drug disposition,
including pharmacokinetics, are outlined. The major part
of the unit consists of a detailed account of selected major
classes of drugs. These include drugs affecting the autonomic
nervous system and cardiovascular system as well as chemical
mediators of pain and inflammation. Emphasis is given to
therapeutic applications. The practical course gives experience
in measuring drug responses in humans. Tutorial topics include
ethical issues in animal and human experimentation.
Coordinator: Dr Yean Yeow Tan
Note: Limited enrolment due to lab places. Please check with the School of Pharmacy before enrolling. |
| |
|
Pharmacology
CSA233 |
The major part of
the unit consists of a detailed account of selected major
classes of drugs. These include drugs affecting the central
nervous system; chemical mediators, pain and inflammation;
and endocrines. Emphasis is given to therapeutic applications.
Tutorial topics include the development and evaluation of
new drugs. Students must have successfully completed CSA232 for entry to CSA233.
Coordinator: Dr Yean Yeow Tan
Note: Limited enrolment due to lab places. Please check with the School of Pharmacy before enrolling. |
Medicinal
Chemistry
CSA227 |
A study of chemical
structure as a determinant of both the physicochemical properties
and biological activity (including metabolic fate) of drug
molecules of both synthetic and natural origin. The application
of such principles to the design and production of new drug
entities is also examined.
Coordinator: Dr
Stephen Aldous
Note: Limited enrolment due to lab places. Please check with the School of Pharmacy before enrolling. |
|
Clinical
Pharmacokinetics
CSA313 |
Studies the factors
influencing the bioavailability and disposition of drugs,and the application of this information to optimise the
therapeutic usefulness of drugs in clinical practice. Particular
emphasis is placed on the clinical role of the pharmacist
in improving the use of drugs through the practical application
of pharmacokinetics. The subject also includes an overview
of statistics in health sciences.
Topics include: formulation factors and
therapeutic activity; route of administration and bioavailability;
developments in drug delivery; estimating drug dosage requirements
in clinical practice; therapeutic drug monitoring; drug
interactions; an overview of sources of inter-patient variability
in pharmacokinetics (eg extremes of age, renal disease,
pharmacogenomics); clinical case studies and pharmacokinetics
of specific drugs.
Unit objective: to develop a good practical
knowledge and understanding of pharmacokinetics through
the use of lecture material, practical exercises and problems.
A key aim is to develop the ability to logically apply relatively
simple pharmacokinetic principles in everyday clinical pharmacy
practice. This is achieved through the extensive use of
clinically-oriented problems.
Coordinator: Professor
Greg Peterson |
Chemotherapy
and Infection
CSA342
/ CSA343
NOT AVAILABLE FOR S3G STUDENTS |
A study of the basic
principles of antimicrobial chemotherapy and biotherapy
followed by a study of infectious disease therapeutics topics,
using case studies.
Topics include: antimicrobial/antiparasitic
chemotherapy and clinical topics in infectious disease,
incorporating directed and self-directed caset studies.
Unit objective: to develop a good practical
knowledge of chemotherapy and biotherapy and their application
to an understanding of the nature and management of infectious
conditions. Emphasis is also placed on preparing the student
for participation in clinical pharmacy teaching rounds.
Coordinator: Mr Peter Tenni
Special Note: Offered subject
to sufficient enrolment numbers. On completion of CSA342
students are awarded an XX result (result shown in another
unit), the final result for this unit is awarded on completion
CSA343. Students are required to enrol concurrently in CSA342
and CSA343. |
Toxicology
CSA333 |
Toxicology is the
study of the harmful effects of chemicals (including drugs)
and other agents. Studies cover general principles of toxicology,
mechanisms of toxicity, systematic toxicology and toxic agents.
Coordinator: Dr Yean Yeow Tan
|
|
|
 |
|
 |